The effects of peptide on lowering blood pressure: a randomized, double blind, placebo-controlled study.
- Conditions
- one
- Registration Number
- JPRN-UMIN000052102
- Lead Sponsor
- Matsumoto City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Not provided
1) Subjects who are undergoing continuous medical treatment. 2) Subjects who regularly use food for specified health uses, functional foods, health foods whose affects this study. 3) Subjects who smoke 20 cigarettes or more per day. 4) Subjects drink alcohol polydipsia (pure alcohol equivalent more than 60 g/day) 5) Subjects whose BMIs are >=30 kg/m^2. 6) Subjects who are under treatment or have a history of disorders such as the heart, liver, kidney, digestive organs, etc. 7) Subjects who have serious allergies to medicines and foods 8) Subjects who are pregnant, planning to become pregnant, or lactating. 9) Subjects who participated in clinical trials of other drugs or foods within one month, or who plan to do just after giving informed consent. 10) Subjects who are judged inappropriate to this trial by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic blood pressure and diastolic blood pressure
- Secondary Outcome Measures
Name Time Method